Management of Shock Complicating Acute Myocardial Infarction

  • A. Marn Pernat
  • M. H. Weil
  • A. Pernat
Conference paper


Cardiogenic shock remains a leading cause of early cardiac death. The mortality rate of cardiogenic shock as a complication of acute myocardial infarction (AMI) exceeds 80%. Large multicenter studies disclose an incidence of 5 to 15% of all instances of AMI admitted to the hospital [1, 2, 3, 4, 5]. Cardiogenic shock is in evidence at the time of hospital admission in only minority of patients. Approximately 90% of patients develop shock during the in hospital stay [5].


Acute Myocardial Infarction Cardiogenic Shock Coronary Artery Bypass Graft Surgery Surgical Revascularization Left Ventricular Filling Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Scheidt S, Ascheim R, Killip III T (1970) Shock after acute myocardial infarction. Am J Cardiol 26:556–564PubMedCrossRefGoogle Scholar
  2. 2.
    Hands ME, Rutherford JD, Muller JE et al (1989) The in-hospital development of cardiogenic shock after myocardial infarction: incidence of occurrence, outcome and prognostic factors. J Am Coll Cardiol 14:40–46PubMedCrossRefGoogle Scholar
  3. 3.
    Goldberg RJ, Gore JM, Alpert JS et al (1991) Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 325:1117–1122PubMedCrossRefGoogle Scholar
  4. 4.
    Garrahy PJ, Henzlova MJ, Forman S et al (1989) Has thrombolytic therapy improved survival from cardiogenic shock? Thrombolysis in myocardial infarction (TIMIII) results. Circulation 80[SupplII]:II–623Google Scholar
  5. 5.
    Holmes DR, Bates ER, Kleiman NS et al (1995) Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 26:668–674PubMedCrossRefGoogle Scholar
  6. 6.
    Hamm CW, Goldmann BU, Heeschen C et al (1997) Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337:1648–1653PubMedCrossRefGoogle Scholar
  7. 7.
    Kishon Y, Oh JK, Schaff H Y et al (1992) Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients. Mayo Clin Proc 67:1023–1030PubMedCrossRefGoogle Scholar
  8. 8.
    Lemery R, Smith HC, Giuliani ER et al (1992) Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol 70: 147–151PubMedCrossRefGoogle Scholar
  9. 9.
    Da Luz PL, Weil MH, Shubin H (1976) Current concepts on mechanisms and treatment of cardiogenic shock. Am Heart J 92:103–113PubMedCrossRefGoogle Scholar
  10. 10.
    Forrester JS, Diamond G, Chatterjee K et al (1976) Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 295:1356–1363PubMedCrossRefGoogle Scholar
  11. 11.
    Cohn JN (1970) Monitoring techniques in shock. Am J Cardiol 26:565–569PubMedCrossRefGoogle Scholar
  12. 12.
    Antman EM, Braunwald E (1997) Hemodynamic disturbances in acute myocardial infarction. Cardiogenic Shock. In: Braunwald E (ed) Heart disease. A textbook of cardiovascular medicine. WB Saunders, Philadelphia, pp 1233–1245Google Scholar
  13. 13.
    Califf RM, Bengtson JR (1994) Cardiogenic shock. New Engl J Med 330:1724–1730PubMedCrossRefGoogle Scholar
  14. 14.
    Gillespie TA, Ambos HD, Sobel BE et al (1977) Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol 39:588–594PubMedCrossRefGoogle Scholar
  15. 15.
    Weil MH, Shubin H, Carlson R (1975) Treatment of circulatory shock. JAMA 231:1280–1286PubMedCrossRefGoogle Scholar
  16. 16.
    Mueller H, Ayres SM, Gregory JJ et al (1970) Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock: Response to L-norepinephrine and isoproterenol. J Clin Invest 49:1885–1902PubMedCrossRefGoogle Scholar
  17. 17.
    ACC/AHA guidelines for the management of patients with acute myocardial infarction (1996) A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28:1328–1428CrossRefGoogle Scholar
  18. 18.
    Gacioch GM, Ellis SG, Lee L. et al (1992) Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol 19:647–653PubMedCrossRefGoogle Scholar
  19. 19.
    Joyce LD, Johnson KE, Toninato CJ et al (1989) Results of the first 100 patients who received Symbion total artificial hearts as a bridge to cardiac transplantation. Circulation 80[Suppl 3]III: 192–201Google Scholar
  20. 20.
    Champagnac D, Claudel JP, Chevalier P et al (1993) Primary cardiogenic shock during acute myocardial infarction: results of emergency cardiac transplantation. Eur Heart J 14:925–929PubMedCrossRefGoogle Scholar
  21. 21.
    DeWood MA, Notske RN, Hensley GR et al (1980) Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 61:1105–1112PubMedCrossRefGoogle Scholar
  22. 22.
    Berger P, Holmes D, Stebbins A et al (1997) Impact of an aggressive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue plasminogen Activator for Coronary Arteries (GUSTO-I) Trial. J Am Coll Cardiol 96:122–127Google Scholar
  23. 23.
    Page DL, Caulfield JB, Kastor JA et al (1971) Myocardial changes associated with cardiogenic shock. N Engl J Med 285:133–137PubMedCrossRefGoogle Scholar
  24. 24.
    Gutovitz AL, Sobel BE, Roberts R (1978) Progressive nature of myocardial injury in selected patients with cardiogenic shock. Am J Cardiol 41:469–475PubMedCrossRefGoogle Scholar
  25. 25.
    Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66:1146–1149PubMedCrossRefGoogle Scholar
  26. 26.
    Prewitt RM, Gu S, Garger PJ et al (1992) Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 20:1626–1633PubMedCrossRefGoogle Scholar
  27. 27.
    Mathey D, Kuck KH, Remmecke J et al (1980) Transluminal recanalization of coronary artery thrombosis: a preliminary report of its application in cardiogenic shock. Eur Heart J 1:207–212PubMedGoogle Scholar
  28. 28.
    Kennedy JW, Gensini GG, Timmis GC et al (1985) Acute myocardial infarction treated with intracoronary streptokinase: a report of the society for cardiac angiography. Am J Cardiol 55:871–877PubMedCrossRefGoogle Scholar
  29. 29.
    Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397–401Google Scholar
  30. 30.
    Holmes DR, Bates E, and the GUSTO investigators (1993) Cardiogenic shock during myocardial infarction. The GUSTO experience with thrombolytic therapy. Circulation 88[Suppl]:I–253 (abstract)Google Scholar
  31. 31.
    Hochman JS, Boland J, Sleeper LA et al (1995) Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Circulation 91:873–881PubMedCrossRefGoogle Scholar
  32. 32.
    O’Neill WW (1992) Angioplasty therapy of cardiogenic shock: are randomized trials necessary? J Am Coll Cardiol 19:915–917PubMedCrossRefGoogle Scholar
  33. 33.
    Moosvi AR, Khaja F, Villanueva L et al (1992) Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 19:907–914PubMedCrossRefGoogle Scholar
  34. 34.
    Lee L, Erbel R, Brown TM et al (1991) Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol 17:599–603PubMedCrossRefGoogle Scholar
  35. 35.
    Hibbard MD, Holmes DR, Bailey KR et al (1992) Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 19:639–646PubMedCrossRefGoogle Scholar
  36. 36.
    Lee L, Bates ER, Pitt B et al (1988) Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 78:1345–1351PubMedCrossRefGoogle Scholar
  37. 37.
    Webb JG, Carere R, Hilton JD et al (1997) Usefulness of coronary stenting in cardiogenic shock. Am J Cardiol 79:81–84PubMedCrossRefGoogle Scholar
  38. 38.
    Kirklin JK, Akins CW, Blackstone EH et al (1991) Guidelines and indications for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 91: 2335–2344Google Scholar
  39. 39.
    O’Connor GT, Plume SK, Olmstead EM et al (1992) Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Circulation 85:2110–2118PubMedCrossRefGoogle Scholar
  40. 40.
    Sergeant P, Blackstone E, Meyns B (1997) Early and late outcome after CABG in patients with evolving myocardial infarction. Eur J Cardiothorac Surg 11:848–856PubMedCrossRefGoogle Scholar
  41. 41.
    Lee JH, Murrell HK, Strony J et al (1997) Risk analysis of coronary bypass surgery after acute myocardial infarction. Surgery 122:675–680PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • A. Marn Pernat
    • 1
  • M. H. Weil
    • 1
    • 2
  • A. Pernat
    • 1
  1. 1.Institute of Critical Care MedicinePalm SpringsUSA
  2. 2.The University of Southern California School of MedicineLos AngelesUSA

Personalised recommendations